AI tool comparison
AI-Scientist-v2 vs ORAC-NT
Which one should you ship with? Here is the side-by-side panel verdict, pricing read, reviewer split, and community vote comparison.
Research & Science
AI-Scientist-v2
Sakana AI's autonomous agent that writes peer-reviewed papers
50%
Panel ship
—
Community
Free
Entry
AI-Scientist-v2 is Sakana AI's second-generation autonomous research system that generates scientific papers end-to-end — from hypothesis formation through experimentation, data analysis, and manuscript writing. It's historically notable for producing the first AI-authored workshop paper accepted through peer review. The v2 system removes reliance on human-authored templates that constrained the original, instead using a progressive agentic tree search guided by an experiment manager agent. This makes it more exploratory across ML domains, though Sakana acknowledges it trades v1's high template success rate for broader generalization with lower per-run success. Costs run roughly $20-25 per full research run using Claude 3.5 Sonnet. The system integrates with Semantic Scholar for literature review and supports OpenAI, Gemini, and Claude via AWS Bedrock. The custom license requires disclosure of AI use in resulting publications — a meaningful ethical constraint for a system that could otherwise flood conferences with AI-generated submissions.
Research
ORAC-NT
MedChem copilot that blocks toxic molecular modifications before you make them
75%
Panel ship
—
Community
Paid
Entry
ORAC-NT is an open-source medicinal chemistry copilot for early-stage drug discovery. Unlike general-purpose AI tools, it actively blocks synthetically infeasible or toxic molecular modifications — it won't just suggest them — and explains exactly why each transformation is rejected before proposing valid alternatives. The tool provides guided transformation pathways for common medicinal chemistry operations: halogenation, methylation, scaffold simplification, bioisosteric replacement, and solubility optimization. Each step generates an audit trail formatted for regulatory documentation, addressing a real gap in AI-assisted drug design where there's no clear chain of reasoning for a discovery team's choices. The target user is a medicinal chemist doing early lead optimization who wants AI assistance but can't afford hallucinated suggestions. ORAC-NT's guardrail-first design philosophy means it says 'no' often, with explanation — the opposite of most AI tools that optimize for appearing helpful.
Reviewer scorecard
“For ML research teams, the $20-25 per run cost to get a draft paper with experiments is genuinely interesting as an ideation tool. The tree search approach that explores multiple experimental directions in parallel is the kind of thing that would take a grad student weeks.”
“The regulatory audit trail feature alone makes this worth evaluating for any pharma team using AI. The FDA is going to want documentation on AI-assisted design decisions, and ORAC-NT is the only open-source tool I've seen that generates that output by design rather than as an afterthought.”
“Sakana's own documentation says v2 has lower success rates than v1 and is 'more exploratory.' Paying $25 for a failed research run with no guarantee of a usable output isn't a workflow most researchers will adopt. The peer review acceptance was a workshop paper — the lowest bar in academic publishing.”
“Drug discovery is a domain where a wrong answer has real stakes, and 'open source with a paid cloud tier' is not how serious pharma teams procure safety-critical software. Until this has been validated against known drug series and peer-reviewed, treating it as anything other than a research prototype would be reckless.”
“This is the beginning of AI as a genuine research collaborator, not just a writing assistant. Within five years, AI-generated hypotheses tested by autonomous agents will be standard practice in computational fields. AI-Scientist-v2 is primitive version 0.2 of that future.”
“AI in drug discovery has mostly been a hype layer on top of existing cheminformatics. ORAC-NT's approach — domain-specific guardrails, explainability, audit trails — is what responsible AI deployment actually looks like in high-stakes science. This design pattern will propagate to other regulated domains.”
“Science communication is a craft, and the idea of fully automating it makes me uncomfortable. The best papers are ones where researchers deeply understand and can defend every methodological choice — a system that writes the paper for you undermines that accountability.”
“The UX philosophy here is fascinating from a design perspective: an AI tool that's deliberately more restrictive than helpful. That's a radical choice that goes against every growth metric. But in professional scientific contexts, trust comes from knowing the tool will say no to bad ideas. That's a design principle worth stealing.”
Weekly AI Tool Verdicts
Get the next comparison in your inbox
New AI tools ship daily. We compare them before you waste an afternoon.